Results 221 to 230 of about 16,847,686 (287)

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

“Low‐Positive” MOG‐IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the prevalence and clinical characteristics of patients with “low‐positive” (LP) MOG‐IgG (titres 1:160–1:320) among adults with a first demyelinating event (FDE) suggestive of multiple sclerosis (MS). Methods From the Barcelona CIS inception cohort, we included adult patients with serum collected ≤ 6 months from the FDE.
Javier Villacieros‐Álvarez   +29 more
wiley   +1 more source

CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is associated with distinct ...
Antonio Bruno   +19 more
wiley   +1 more source

Digital transformation and emerging technologies in healthcare and pharmaceutical supply chains: a bibliometric mapping review. [PDF]

open access: yesFront Digit Health
Zhalbirova G   +5 more
europepmc   +1 more source

Exploring Bias in Medical Applications of Large Language Models: Protocol for a Systematic Review. [PDF]

open access: yesJMIR Res Protoc
Rao S   +9 more
europepmc   +1 more source

Protein Quantification Platforms For Use In Critical Care Precision Medicine Trials: A Scoping Review. [PDF]

open access: yesCrit Care Explor
McMullan RR   +14 more
europepmc   +1 more source

Advancing Family Medicine Through Dyadic Electronic Medical Record Linkage in Dementia Care. [PDF]

open access: yesAnn Fam Med
Robitaille A   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy